{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:42:20Z","timestamp":1768869740053,"version":"3.49.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"10","funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of China","doi-asserted-by":"publisher","award":["2012ZX09101-318"],"award-info":[{"award-number":["2012ZX09101-318"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of China","doi-asserted-by":"publisher","award":["2010DFB32890"],"award-info":[{"award-number":["2010DFB32890"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of China","doi-asserted-by":"publisher","award":["2012AA02A404"],"award-info":[{"award-number":["2012AA02A404"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"crossref","award":["2012ZX008"],"award-info":[{"award-number":["2012ZX008"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,15]]},"DOI":"10.1093\/cid\/cix110","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T08:57:10Z","timestamp":1487149030000},"page":"1317-1325","source":"Crossref","is-referenced-by-count":26,"title":["Immune Serum From Sabin Inactivated Poliovirus Vaccine Immunization Neutralizes Multiple Individual Wild and Vaccine-Derived Polioviruses"],"prefix":"10.1093","volume":"64","author":[{"given":"Mingbo","family":"Sun","sequence":"first","affiliation":[{"name":"Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Disease, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changgui","family":"Li","sequence":"additional","affiliation":[{"name":"Third Division of Viral Vaccines, National Institutes for Food and Drug Control, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbo","family":"Xu","sequence":"additional","affiliation":[{"name":"Ministry of Health Key Laboratory for Medical, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoyang","family":"Liao","sequence":"additional","affiliation":[{"name":"No. 5 Department of Biological Products, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongcheng","family":"Li","sequence":"additional","affiliation":[{"name":"Vaccine Clinical Research Center, Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, Nanning, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[{"name":"No. 4 Department of Biological Products, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Li","sequence":"additional","affiliation":[{"name":"Vaccine Clinical Research Center, Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, Nanning, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Cai","sequence":"additional","affiliation":[{"name":"No. 4 Department of Biological Products, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Yan","sequence":"additional","affiliation":[{"name":"Ministry of Health Key Laboratory for Medical, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanchun","family":"Che","sequence":"additional","affiliation":[{"name":"Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Disease, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifang","family":"Ying","sequence":"additional","affiliation":[{"name":"Third Division of Viral Vaccines, National Institutes for Food and Drug Control, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Third Division of Viral Vaccines, National Institutes for Food and Drug Control, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijuan","family":"Yang","sequence":"additional","affiliation":[{"name":"No. 4 Department of Biological Products, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Ma","sequence":"additional","affiliation":[{"name":"No. 4 Department of Biological Products, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Ma","sequence":"additional","affiliation":[{"name":"No. 5 Department of Biological Products, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang","family":"Ji","sequence":"additional","affiliation":[{"name":"No. 4 Department of Biological Products, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Shi","sequence":"additional","affiliation":[{"name":"Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Disease, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shude","family":"Jiang","sequence":"additional","affiliation":[{"name":"Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Disease, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qihan","family":"Li","sequence":"additional","affiliation":[{"name":"Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Disease, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,4,13]]},"reference":[{"key":"key\n\t\t\t\t20180328133819_CIT0001","first-page":"595","article-title":"Medicine and the media: polio still paralyses (Albert Sabin, Jonas Salk)","volume":"18","author":"Dixon","year":"1977","journal-title":"Br J Hosp Med"},{"key":"key\n\t\t\t\t20180328133819_CIT0002","first-page":"499","article-title":"The Sabin live poliovirus vaccination trials in the USSR, 1959","volume":"64","author":"Horstmann","year":"1991","journal-title":"Yale J Biol Med"},{"key":"key\n\t\t\t\t20180328133819_CIT0003","first-page":"241","article-title":"Wkly Epidemiol Rec","author":"Introduction of inactivated poliovirus vaccine into oral poliovirus vaccine-using countries","year":"2003"},{"key":"key\n\t\t\t\t20180328133819_CIT0004","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/rmv.401","article-title":"Polio eradication: the OPV paradox","volume":"13","author":"Dowdle","year":"2003","journal-title":"Rev Med Virol"},{"key":"key\n\t\t\t\t20180328133819_CIT0005","doi-asserted-by":"crossref","first-page":"20120140","DOI":"10.1098\/rstb.2012.0140","article-title":"The final stages of the global eradication of poliomyelitis","volume":"368","author":"Grassly","year":"2013","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"key\n\t\t\t\t20180328133819_CIT0006","doi-asserted-by":"crossref","first-page":"S259","DOI":"10.1093\/infdis\/jiu164","article-title":"Maintaining polio-free certification in the World Health Organization Western Pacific Region for over a decade","volume":"210","author":"Adams","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328133819_CIT0007","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4321\/S1135-57272013000500008","article-title":"Polio vaccines, eradication and posterradication [in Spanish]","volume":"87","author":"Salmer\u00f3n Garc\u00eda","year":"2013","journal-title":"Rev Esp Salud Publica"},{"key":"key\n\t\t\t\t20180328133819_CIT0008","article-title":"FACT FILE: Polio Eradication and Endgame Strategic Plan 2013\u20132018. Global Polio Eradication Initiative. Geneva, Switzerland: WHO","author":"World Health Organization","year":"2012"},{"key":"key\n\t\t\t\t20180328133819_CIT0009","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1093\/infdis\/jiu184","article-title":"Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden","volume":"210","author":"Platt","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328133819_CIT0010","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1093\/infdis\/jiu295","article-title":"Vaccine-derived polioviruses","volume":"210","author":"Burns","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328133819_CIT0011","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4155\/ppa.12.70","article-title":"Innovative IPV from attenuated Sabin poliovirus or newly designed alternative seed strains","volume":"1","author":"Hamidi","year":"2012","journal-title":"Pharm Pat Anal"},{"key":"key\n\t\t\t\t20180328133819_CIT0012","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1016\/j.vaccine.2014.04.023","article-title":"Polio vaccines: WHO position paper, January 2014\u2014recommendations","volume":"32","author":"World Health Organization","year":"2014","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180328133819_CIT0013","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1016\/j.vaccine.2014.07.029","article-title":"Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants","volume":"32","author":"Verdijk","year":"2014","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180328133819_CIT0014","doi-asserted-by":"crossref","first-page":"108","DOI":"10.5501\/wjv.v1.i4.108","article-title":"History of polio vaccination","volume":"1","author":"Baicus","year":"2012","journal-title":"World J Virol"},{"key":"key\n\t\t\t\t20180328133819_CIT0015","first-page":"480","article-title":"On the antigenicity of vaccines against poliomyelitis. Inactivated vaccines and vaccinations by attenuated living viruses [in French]","volume":"144","author":"Lepine","year":"1960","journal-title":"Bull Acad Natl Med"},{"key":"key\n\t\t\t\t20180328133819_CIT0016","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0264-410X(98)00409-5","article-title":"Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains","volume":"17","author":"Kersten","year":"1999","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180328133819_CIT0017","article-title":"Guidelines for the safe production and quality control of inactivated poliomyelitis vaccine manufactured from wild polioviruses: addendum, 2003, to the recommendations for the production and quality control of poliomyelitis vaccine (inactivated)","volume":"926","author":"World Health Organization","year":"2004","journal-title":"Technical Report Series. Geneva, Switzerland: WHO"},{"key":"key\n\t\t\t\t20180328133819_CIT0018","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/infdis\/jir723","article-title":"Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial","volume":"205","author":"Liao","year":"2012","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328133819_CIT0019","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.vaccine.2013.12.025","article-title":"Dynamic profiles of neutralizing antibody responses elicited in rhesus monkeys immunized with a combined tetravalent DTaP-Sabin IPV candidate vaccine","volume":"32","author":"Sun","year":"2014","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180328133819_CIT0020","volume-title":"National EPI vaccine schedule","author":"Program","year":"2007"},{"key":"key\n\t\t\t\t20180328133819_CIT0021","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1586\/erv.11.51","article-title":"Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains","volume":"10","author":"Verdijk","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t20180328133819_CIT0022","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-4939-3292-4","volume-title":"Poliovirus: methods and protocols, methods in molecular biology","author":"Martin","year":"2016"},{"key":"key\n\t\t\t\t20180328133819_CIT0023","doi-asserted-by":"crossref","first-page":"e107697","DOI":"10.1371\/journal.pone.0107697","article-title":"Molecular characterization and phylogenetic relationship of wild type 1 poliovirus strains circulating across Pakistan and Afghanistan bordering areas during 2010\u20132012","volume":"9","author":"Shaukat","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328133819_CIT0024","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1128\/JCM.33.12.3252-3256.1995","article-title":"Molecular characterization of a wild poliovirus type 3 epidemic in the Netherlands (1992 and 1993)","volume":"33","author":"Mulders","year":"1995","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180328133819_CIT0025","author":"World Health Organization.","year":"2011"},{"key":"key\n\t\t\t\t20180328133819_CIT0026","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/risa.12022","article-title":"Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs)","volume":"33","author":"Duintjer Tebbens","year":"2013","journal-title":"Risk Anal"},{"key":"key\n\t\t\t\t20180328133819_CIT0027","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.4161\/21645515.2014.981115","article-title":"The polio endgame","volume":"10","author":"Minor","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"key\n\t\t\t\t20180328133819_CIT0028","first-page":"4","article-title":"History of development of the live poliomyelitis vaccine from Sabin attenuated strains in 1959 and idea of poliomyelitis eradication","volume":"58","author":"Lashkevich","year":"2013","journal-title":"Vopr Virusol"},{"key":"key\n\t\t\t\t20180328133819_CIT0029","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0140-6736(13)60825-9","article-title":"Ending polio\u2014if at first you don\u2019t succeed","volume":"381","author":"Maurice","year":"2013","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328133819_CIT0030","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.1016\/j.vaccine.2011.09.059","article-title":"Safe landing for global polio eradication: a perspective","volume":"29","author":"Arita","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180328133819_CIT0031","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/493285a","article-title":"Vaccine switch urged for polio endgame","volume":"493","author":"Callaway","year":"2013","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180328133819_CIT0032","first-page":"6","article-title":"Meeting of the Strategic Advisory Group of Experts on Immunization, November 2013\u2014conclusions and recommendations","volume":"1","author":"World Health Organization","year":"2014","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20180328133819_CIT0033","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.1965.03090210036010","article-title":"Oral poliovirus vaccine. History of its development and prospects for eradication of poliomyelitis","volume":"194","author":"Sabin","year":"1965","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180328133819_CIT0034","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1099\/vir.0.036988-0","article-title":"The polio-eradication programme and issues of the end game","volume":"93","author":"Minor","year":"2012","journal-title":"J Gen Virol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/64\/10\/1317\/19284464\/cix110.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T12:14:01Z","timestamp":1601640841000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/64\/10\/1317\/3737858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,13]]},"references-count":34,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,4,13]]},"published-print":{"date-parts":[[2017,5,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cix110","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,5,15]]},"published":{"date-parts":[[2017,4,13]]}}}